These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 22959703)
1. [Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]. Fontaine B Rev Neurol (Paris); 2012 Nov; 168(11):833-5. PubMed ID: 22959703 [TBL] [Abstract][Full Text] [Related]
8. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Bomprezzi R; Ringnér M; Kim S; Bittner ML; Khan J; Chen Y; Elkahloun A; Yu A; Bielekova B; Meltzer PS; Martin R; McFarland HF; Trent JM Hum Mol Genet; 2003 Sep; 12(17):2191-9. PubMed ID: 12915464 [TBL] [Abstract][Full Text] [Related]
9. Antibodies as biological markers for pathophysiological processes in MS. Reindl M; Khalil M; Berger T J Neuroimmunol; 2006 Nov; 180(1-2):50-62. PubMed ID: 16934337 [TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis. Thamilarasan M; Koczan D; Hecker M; Paap B; Zettl UK Autoimmun Rev; 2012 Jan; 11(3):174-9. PubMed ID: 21621006 [TBL] [Abstract][Full Text] [Related]
11. Bayesian approach to searching for susceptibility genes: Gc2 and EsD1 alleles and multiple sclerosis. Di Bacco M; Luiselli D; Manca ML; Siciliano G Coll Antropol; 2002 Jun; 26(1):77-84. PubMed ID: 12137326 [TBL] [Abstract][Full Text] [Related]
12. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Oksenberg JR; Baranzini SE; Sawcer S; Hauser SL Nat Rev Genet; 2008 Jul; 9(7):516-26. PubMed ID: 18542080 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms associated with the development and clinical course of multiple sclerosis (review). Kallaur AP; Kaimen-Maciel DR; Morimoto HK; Watanabe MA; Georgeto SM; Reiche EM Int J Mol Med; 2011 Oct; 28(4):467-79. PubMed ID: 21720720 [TBL] [Abstract][Full Text] [Related]
14. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Hauser SL; Oksenberg JR Neuron; 2006 Oct; 52(1):61-76. PubMed ID: 17015227 [TBL] [Abstract][Full Text] [Related]
15. [Genetic susceptibility to multiple sclerosis (MS). INSERM Network of Clinical Research on the Genetic Susceptibility to MS]. Fontaine B Rev Neurol (Paris); 1998 Sep; 154(8-9):601-5. PubMed ID: 9809375 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosis. Schrijver HM; Hooper-van Veen T; van Belzen MJ; Crusius JB; Peña AS; Barkhof F; Polman CH; Uitdehaag BM Eur J Immunogenet; 2004 Jun; 31(3):133-40. PubMed ID: 15182327 [TBL] [Abstract][Full Text] [Related]
18. The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility. Bahreini SA; Jabalameli MR; Saadatnia M; Zahednasab H J Neuroimmunol; 2010 Dec; 229(1-2):5-15. PubMed ID: 20832869 [TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis: disease biomarkers as indicated by pathophysiology. Berger T; Reindl M J Neurol Sci; 2007 Aug; 259(1-2):21-6. PubMed ID: 17367811 [TBL] [Abstract][Full Text] [Related]